Interview 26 May 2021Immuno-Oncology: From Science Fiction to the Mainstream In just a couple of decades, immuno-oncology has taken center stage in the biotechnology industry. We discuss the evolution of… May 26, 2021 - 7 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Interview 19 May 2021Are Biotech Startups Ready for Augmented Reality? Augmented reality is starting to become a part of the manufacturing process of pharma and biotech companies. Paul Haimes, Vice… May 19, 2021 - 8 minutesmins - By Carlos de Rojas Share WhatsApp Twitter Linkedin Email
Interview 10 May 2021The Rollercoaster of Repurposing an Arthritis Drug for Covid-19 The Covid-19 pandemic created an opportunity for many biotech companies to repurpose their existing programs into vaccines and treatments for… May 10, 2021 - 8 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Interview 21 Apr 2021Changing Attitudes on Vaccine and Public Health Investment The Covid-19 pandemic has pushed investment and research into vaccines and public health, but will such interest continue in the… April 21, 2021 - 5 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Interview 5 Apr 2021Base Editing: The Next Frontier in Genome Editing Technology Jonathan Frampton, Corporate Development Partner at Horizon Discovery, a Perkin Elmer company, shares his insights into the promises of base… April 5, 2021 - 4 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Interview 15 Mar 2021Developing a Vaccine that Protects Against Covid-19 Variants Despite the promise of several approved Covid-19 vaccines and the widespread rollout of vaccination programs around the world, recent mutations… March 15, 2021 - 8 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Interview 3 Mar 2021The Promises of CRISPR Genome Editing in Biomedicine Tony Ho, Head of Research and Development at CRISPR Therapeutics, offers his insights into the advantages of CRISPR gene editing… March 3, 2021 - 5 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Interview 22 Feb 2021How Automation Can Augment Drug Discovery Research Robotics and artificial intelligence are rapidly changing the way we discover drugs. Martin-Immanuel Bittner, CEO and co-founder of Arctoris, discusses… February 22, 2021 - 8 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Interview 1 Feb 2021Democratized DNA Synthesis: A Game-Changer Against Covid-19 DNA synthesis is one of the pillars of Covid-19 research that has suffered supply disruptions during lockdowns. Thomas Ybert, CEO… February 1, 2021 - 6 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 23 Nov 2020CDMOs Are the Unsung Heroes of the Gene and Cell Therapy Revolution Cell and gene therapy is booming amid the ongoing pandemic, and this is driving up demand for synthetic DNA products,… November 23, 2020 - 5 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Interview 28 Oct 2020Do Natural Killer Cells Hold the Key to Treating Blood Cancers? Novel immunotherapies, like T cell therapy, may have shown recent successes but they also come with a number of setbacks,… October 28, 2020 - 7 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Interview 5 Oct 2020How is Germany Meeting Patient Demand for Medical Cannabis? Since Germany legalized cannabis for medical use in 2017, we have frequently spoken to Peter Homberg, Partner and Head of… October 5, 2020 - 7 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Interview 28 Sep 2020From Big Pharma to Startup CEO: Lessons from Kymriah Developer Gaurav Shah Novartis’ Kymriah, one of the first CAR T-cell therapies to be approved to treat blood cancer, has revolutionized both oncology… September 28, 2020 - 9 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Interview 9 Sep 2020Biotech Investment in Norway: An Alternative Approach Norway has not typically been an attractive region for biotech investors, so when Masha Strømme set up her own investment… September 9, 2020 - 6 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Interview 2 Sep 2020An Alzheimer’s Vaccine Challenged the Consensus for 25 Years For decades, Alzheimer's disease research focused on a hypothesis that has increasingly been contested. A team of scientists in Slovakia… September 2, 2020 - 8 minutesmins - By Farhan Mitha Share WhatsApp Twitter Linkedin Email
Interview 29 Jul 2020Medical Cannabis: Regulatory Issues, Patient Demand, and Pricing Changes in Germany While the coronavirus pandemic has shaken many industries to their core, the European medical cannabis industry continues to flourish. A… July 29, 2020 - 8 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Interview 21 May 2020What 2019 Can Teach About European Biotech Investments Going Forward Following 2018’s bumper harvest for equity funding in European biotech, 2019 proved even more lucrative, particularly for private biotech companies.… May 21, 2020 - 9 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 15 Apr 2020Investing in the Microbiome in the Age of Covid-19 and Beyond For Isabelle de Cremoux, CEO and Managing Partner at Seventure Partners, 2020 was going to be an important year for… April 15, 2020 - 7 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Interview 23 Mar 2020Riding the Wave of Cambridge Entrepreneurship The University of Cambridge is world-famous, but unlike its US equivalent, the city isn’t as well known for its startup… March 23, 2020 - 9 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Interview 12 Feb 2020Boosting Cancer Research by Unlocking Genomic Data More genomic data is produced today than ever before as it’s fundamental to the development of new medicines. But although… February 12, 2020 - 6 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email